Caribou Biosciences
Stock Forecast, Prediction & Price Target
Caribou Biosciences Financial Estimates
Caribou Biosciences Revenue Estimates
Caribou Biosciences EBITDA Estimates
Caribou Biosciences Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $9.59M N/A | $13.85M 44.31% | $34.47M 148.91% | Avg: $12.56M Low: $9.23M High: $15.53M avg. -63.55% | Avg: $74.97M Low: $31.02M High: $108.17M avg. 496.64% | Avg: $71.24M Low: $29.47M High: $102.78M avg. -4.97% | Avg: $376.72M Low: $155.86M High: $543.54M avg. 428.80% |
Net Income
% change YoY
| $-66.92M N/A | $-99.42M -48.56% | $-102.07M -2.66% | Avg: $-217.58M Low: $-222.16M High: $-109.23M avg. -113.16% | Avg: $-213.22M Low: $-212.56M High: $-49.28M avg. 2.00% | Avg: $-178.98M Low: $-282.02M High: $-42.57M avg. 16.05% | Avg: $-73.62M Low: $-116.00M High: $-17.51M avg. 58.86% |
EBITDA
% change YoY
| $-68.17M N/A | $-106.26M -55.86% | $-112.53M -5.89% | Avg: $-12.56M Low: $-15.53M High: $-9.23M avg. 88.83% | Avg: $-74.97M Low: $-108.17M High: $-31.02M avg. -496.64% | Avg: $-71.24M Low: $-102.78M High: $-29.47M avg. 4.97% | Avg: $-376.72M Low: $-543.54M High: $-155.86M avg. -428.80% |
EPS
% change YoY
| -$1.11 N/A | -$1.64 -47.74% | -$1.38 15.85% | Avg: -$2.09 Low: -$3.01 High: -$1.48 avg. -51.25% | Avg: -$1.95 Low: -$2.88 High: -$0.67 avg. 6.69% | Avg: -$2.43 Low: -$3.82 High: -$0.58 avg. -24.51% | Avg: -$1 Low: -$1.57 High: -$0.24 avg. 58.86% |
Operating Expenses
% change YoY
| $76.57M N/A | $120.25M 57.03% | $150.53M 25.18% | Avg: $25.81M Low: $18.98M High: $31.91M avg. -82.84% | Avg: $154.04M Low: $63.73M High: $222.25M avg. 496.64% | Avg: $146.37M Low: $60.56M High: $211.19M avg. -4.97% | Avg: $774.02M Low: $320.25M High: $1.11B avg. 428.80% |
FAQ
What is Caribou Biosciences stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -9.06% in 2025-2028.
We have gathered data from 7 analysts. Their low estimate is -222.16M, average is -217.58M and high is -109.23M.
What is Caribou Biosciences stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 214.22% in 2025-2028.
We have gathered data from 6 analysts. Their low revenue estimate is $9.23M, average is $12.56M and high is $15.53M.
What is Caribou Biosciences stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -2.55% in 2025-2028.
We have gathered data from 7 analysts. Their low earnings per share estimate is -$3.01, average is -$2.09 and high is $-1.48.
What is the best performing analyst?
In the last twelve months analysts have been covering Caribou Biosciences stock. The most successful analyst is Liisa Bayko.